Client Result

Internal Lab Buildout Strategy

Project Overview

A large pharmaceutical company engaged DeciBio to evaluate strategies for an internal build of a lab to support clinical and commercial opportunities in oncology

DeciBio Approach

Secondary Research

  • Conducted analysis of key technologies and platforms to understand potential use cases and fit for client needs in the lab build
  • Evaluated the tangible and intangible value of an internal lab and trade-offs between internal build vs. outsourcing

‍Primary Research

  • Conducted 25 telephone interviews with, lab directors, and technology KOLs to gather insights on platform / workflow requirements and evolving landscape (e.g., regulatory)
  • Conducted 14 internal interviews to determine internal hypotheses, anticipated sample volumes and associated costs

Quantitative Analysis

  • Built a comprehensive financial model, including CapEx / OpEx to calculate the breakeven time frame using sample volume projections
  • Determined NPV under various model scenarios

At a glance
25
Stakeholder Interviews
4
Lab Build Timing Scenarios
14
Client Stakeholders Engaged
Outcomes

DeciBio delivered a presentation to the leadership team, key takeaways included:

  • Recommendation for an internal build based on cost savings and additional intangible benefits
  • Evaluation of associated risks of build
  • Determined lab design configurations and built roadmap (e.g., personnel requirements, CLIA/CAP, instruments, layout etc.)

Timeline

7 weeks

Geographic Scope

U.S.

Industry

Pharma & Biotech

capabilities

Voice-Of-Customer Research

Due Diligence

Biomarker and Diagnostic Strategy

Related Client Results

Precision Medicine is evolving at a rapid pace

Discover how we can help

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.